Low Very low-Density Lipoprotein Cholesterol but High Very low-Density Lipoprotein Receptor mRNA Expression in Peripheral White Blood Cells: An Atherogenic Phenotype for Atherosclerosis in a Community-Based Population

被引:7
|
作者
Zhao, Fan [1 ]
Qi, Yue [1 ]
Liu, Jing [1 ]
Wang, Wei [1 ]
Xie, Wuxiang [1 ]
Sun, Jiayi [1 ]
Liu, Jun [1 ]
Hao, Yongchen [1 ]
Wang, Miao [1 ]
Li, Yan [1 ]
Zhao, Dong [1 ]
机构
[1] Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol,Beijing An Zhen Hosp,Minist Educ, Beijing, Peoples R China
来源
EBIOMEDICINE | 2017年 / 25卷
基金
中国国家自然科学基金;
关键词
Very low-density lipoprotein cholesterol; Very low-density lipoprotein receptor; Carotid atherosclerosis; Community-based study; HIGH-AFFINITY RECEPTOR; CAROTID PLAQUE AREA; VLDL RECEPTOR; ULTRASOUND MEASUREMENT; REMNANT CHOLESTEROL; DISEASE; PROGRESSION; LDL; RISK; HDL;
D O I
10.1016/j.ebiom.2017.08.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Very low-density lipoprotein cholesterol (VLDL-C), via binding very low-density lipoprotein receptor (VLDLR), can induce the development of atherosclerosis. Besides monocytes, VLDLR expression is detected in various peripheral white blood cells (WBCs), yet its underlying role remains unclear. We thereby aimed to test the hypothesis that VLDLR in all types of peripheral WBCs may be involved in the association between VLDL-C and atherosclerosis. VLDLR mRNA expression in peripheral WBC and plasma VLDL-C levels were measured in 747 participants from a community-based study. Plaque prevalence and total plaque area (TPA) were used to evaluate the burden of carotid atherosclerosis. VLDL-C was positively associated with atherosclerosis risk, whereas this association was modified by VLDLR mRNA level. In participants with the lowest VLDL-C but the highest VLDLR mRNA expression, the risk for plaque prevalence unexpectedly was the highest. This association was also observed for TPA. Moreover, this association remained unchanged after adjusting for WBC or monocytes. Our findings described an atherogenic phenotype characterized by low VLDL-C but high VLDLR mRNA expression in peripheral WBCs, which suggested that VLDLR in all types of peripheral WBCs may be involved in lipid deposition, and VLDL-C and VLDLR may co-determine the development of atherosclerosis. (C) 2017 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 50 条
  • [21] Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment
    Lahoz, C
    Peña, R
    Mostaza, JM
    Laguna, F
    García-Iglesias, MF
    Taboada, M
    Pintó, X
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (06): : 741 - 747
  • [22] Simultaneous Determination of High-Density Lipoprotein, Very Low-Density Lipoprotein and Low-Density Lipoprotein Subclass in Human Serum by Microchip CE
    Wang, Hua
    Han, Chongxu
    Wang, Huimin
    Jin, Qinghui
    Wang, Daxin
    Cao, Li
    Wang, Guangzhou
    CHROMATOGRAPHIA, 2011, 74 (11-12) : 799 - 805
  • [23] Simultaneous Determination of High-Density Lipoprotein, Very Low-Density Lipoprotein and Low-Density Lipoprotein Subclass in Human Serum by Microchip CE
    Hua Wang
    Chongxu Han
    Huimin Wang
    Qinghui Jin
    Daxin Wang
    Li Cao
    Guangzhou Wang
    Chromatographia, 2011, 74 : 799 - 805
  • [24] STRUCTURE OF EGG-YOLK VERY LOW-DENSITY LIPOPROTEIN - POLYDISPERSITY OF VERY LOW-DENSITY LIPOPROTEIN AND ROLE OF LIPOVITELLENIN IN STRUCTURE
    EVANS, RJ
    BAUER, DH
    BANDEMER, SL
    VAGHEFI, SB
    FLEGAL, CJ
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1973, 154 (02) : 493 - 500
  • [25] INTERACTION OF LIPOLYTIC PRODUCTS OF VERY LOW-DENSITY LIPOPROTEIN WITH HIGH-DENSITY LIPOPROTEIN
    TAM, SP
    BRECKENRIDGE, WC
    ARTERIOSCLEROSIS, 1982, 2 (05): : A444 - A444
  • [26] Very low-density lipoprotein in the cord blood of preterm neonates
    Yonezawa, Ryuta
    Okada, Tomoo
    Kitamura, Tomomi
    Fujita, Hidetoshi
    Inami, Ikuhiro
    Makimoto, Masami
    Hosono, Shigeharu
    Minato, Michiyoshi
    Takahashi, Shigeru
    Mugishima, Hideo
    Yamamoto, Tatsuo
    Masaoka, Naoki
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (05): : 704 - 707
  • [27] Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis
    Wang, Jin-Kai
    Li, Yang
    Zhao, Xiao-Lu
    Liu, Yuan-Bin
    Tan, Jing
    Xing, Yu-Ying
    Adi, Dilare
    Wang, Yong-Tao
    Fu, Zhen-Yan
    Ma, Yi-Tong
    Liu, Song-Mei
    Liu, Yong
    Wang, Yan
    Shi, Xiong-Jie
    Lu, Xiao-Yi
    Song, Bao-Liang
    Luo, Jie
    CIRCULATION, 2022, 145 (09) : 675 - 687
  • [28] LOW-DENSITY LIPOPROTEIN CHOLESTEROL REDUCTION IN PATIENTS AT VERY HIGH CARDIOVASCULAR RISK
    Cherubini, A.
    Tollardo, M.
    Palcic, S.
    Scagnetto, A.
    Russo, G.
    Capelletto, C.
    Bollini, M.
    Di Lenarda, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [29] Discordance Between Very Low-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort
    Seehusen, Kristina E.
    Remaley, Alan T.
    Sampson, Maureen
    Meeusen, Jeffrey W.
    Larson, Nicholas B.
    Decker, Paul A.
    Killian, Jill M.
    Takahashi, Paul Y.
    Roger, Veronique L.
    Manemann, Sheila M.
    Lam, Reyna
    Bielinski, Suzette J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (08):
  • [30] DISTRIBUTION OF BETA-LIPOPROTEIN BETWEEN LOW-DENSITY AND VERY LOW-DENSITY LIPOPROTEINS
    JONES, RJ
    ALSADIR, J
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1971, 78 (06): : 994 - &